Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

PHASE2TerminatedINTERVENTIONAL
Enrollment

339

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

dutogliptin

400 mg QD

Trial Locations (55)

Unknown

Fullerton

Long Beach

Orange

San Diego

Kissimmee

Melbourne

New Port Richey

Gurnee

Wichita

Kansas City

Henderson

Las Vegas

Berlin

Margate City

Trenton

Charlotte

Winston-Salem

Cincinnati

Oklahoma City

Medford

Warminster

Columbia

Greer

Dallas

San Antonio

Salt Lake City

Norfolk

Cuidad Autonoma de Buenos Aires

La Plata

Lanús Este

Morón

Quilmes

Corrientes

Calgary

Red Deer

Mount Pearl

St. John's

Etobicoke

London

Samia

Toronto

Cornwall

Mirabel

Montreal

Ellisbridge

Banjara Hills

Punjagutta

Pune

Tardeo

Dhantoli

Chennai

Guadalajara

Mexico City

Morelia

Monterrey N. L.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Phenomix

INDUSTRY